Application 021887
- Type
- NDA
- Sponsor
- GLAXOSMITHKLINE CONS
Application Products
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ALLI | ORLISTAT | CAPSULE;ORAL | 60MG | Yes | Yes |
NDC Listings For This Application
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0135-0461 | ALLI | orlistat | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0135-0461 | ALLI | orlistat | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |
| 0135-0461 | ALLI | orlistat | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | NDA | Current |